123 related articles for article (PubMed ID: 192067)
1. Effects of dibutyryl cyclic adenosinemonophosphate and prostaglandin E1 on platelet aggregation and shape changes.
Wang TY; Hussey CV; Garancis JC
Am J Clin Pathol; 1977 Apr; 67(4):362-7. PubMed ID: 192067
[TBL] [Abstract][Full Text] [Related]
2. Cyclic adenosine 3',5'-monophosphate inhibits the availability of arachidonate to prostaglandin synthetase in human platelet suspensions.
Minkes M; Stanford N; Chi MM; Roth GJ; Raz A; Needleman P; Majerus PW
J Clin Invest; 1977 Mar; 59(3):449-54. PubMed ID: 190267
[TBL] [Abstract][Full Text] [Related]
3. Cyclic AMP and platelet prostaglandin synthesis.
Gerrard JM; Peller JD; Krick TP; White JG
Prostaglandins; 1977 Jul; 14(1):39-50. PubMed ID: 197570
[TBL] [Abstract][Full Text] [Related]
4. Modulation of platelet cyclic nucleotide content by PGE1 and the prostaglandin endoperoxide PGG2.
Miller OV; Gorman RR
J Cyclic Nucleotide Res; 1976; 2(2):79-87. PubMed ID: 177467
[TBL] [Abstract][Full Text] [Related]
5. Effect of adenyl-cyclase activators, phosphodiesterase inhibitors and pyridoxal-5-phosphate on platelet aggregation and adenosine-3'-5'-cyclic monophosphate accumulation.
Zahavi M; Zahavi J; Kakkar VV
Thromb Haemost; 1984 Oct; 52(2):205-9. PubMed ID: 6098048
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of ADP-induced responses in human platelets by agents elevating the cyclic AMP level: comparison of aggregation and shape change.
Steen VM; Holmsen H
Thromb Haemost; 1984 Dec; 52(3):333-5. PubMed ID: 6099615
[TBL] [Abstract][Full Text] [Related]
7. [Effect of prostaglandins E1 and E2 on thrombocyte form and aggregation].
Antonikov IM; Alekseev OV; Chernukh AM
Biull Eksp Biol Med; 1982 Apr; 93(4):11-3. PubMed ID: 6952942
[TBL] [Abstract][Full Text] [Related]
8. Human platelet secretion and aggregation induced by calcium ionophores. Inhibition by PGE1 and dibutyryl cyclic AMP.
Feinstein MB; Fraser C
J Gen Physiol; 1975 Nov; 66(5):561-81. PubMed ID: 172596
[TBL] [Abstract][Full Text] [Related]
9. The effect of pyridoxal-5-phosphate on the inhibition of platelet aggregation and adenosine-3'-5'-cyclic monophosphate accumulation in human platelets.
Zahavi M; Zahavi J; Kakkar VV
Life Sci; 1984 Oct; 35(14):1497-503. PubMed ID: 6090838
[TBL] [Abstract][Full Text] [Related]
10. Interrelation of prostaglandin endoperoxide (prostaglandin G2) and cyclic 3',5'-adenosine monophosphate in human blood platelets.
Salzman EW
Biochim Biophys Acta; 1977 Aug; 499(1):48-60. PubMed ID: 196670
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of adenylate cyclase by adenosine analogues in preparations of broken and intact human platelets. Evidence for the unidirectional control of platelet function by cyclic AMP.
Haslam RJ; Davidson MM; Desjardins JV
Biochem J; 1978 Oct; 176(1):83-95. PubMed ID: 215136
[TBL] [Abstract][Full Text] [Related]
12. Effects of prostaglandins, derivatives of cyclic 3':5'-AMP, theophylline, cholinergic agents and colchicine on clot retraction in dilute platelet-rich plasma and gel-separated platelet test systems.
Moake JL; Cimo PL; Widmer K; Peterson DM; Gum JR
Thromb Haemost; 1977 Aug; 38(2):420-8. PubMed ID: 202038
[TBL] [Abstract][Full Text] [Related]
13. [Cyclic adenosine monophosphate, prostaglandin E and aggregation of blood platelets in man].
Ardelt W
Fortschr Med; 1977 Feb; 95(6):366-70. PubMed ID: 190100
[TBL] [Abstract][Full Text] [Related]
14. Substances that increase the cyclic AMP content prevent platelet aggregation and the concurrent release of pharmacologically active substances evoked by arachidonic acid.
Vargaftig BB; Chignard M
Agents Actions; 1975 May; 5(2):137-44. PubMed ID: 51579
[TBL] [Abstract][Full Text] [Related]
15. Relation between the inhibition of aggregation and the concentration of cAMP in human and rat platelets.
Michel H; Caen JP; Born GV; Miller R; D'Auriac GA; Meyer P
Br J Haematol; 1976 May; 33(1):27-38. PubMed ID: 178342
[TBL] [Abstract][Full Text] [Related]
16. Mode of action of ticlopidine in inhibition of platelet aggregation in the rat.
Ashida SI; Abiko Y
Thromb Haemost; 1979 Apr; 41(2):436-49. PubMed ID: 224522
[TBL] [Abstract][Full Text] [Related]
17. 6-Keto-prostaglandin E1 inhibits the aggregation of human platelets.
Wong PY; McGiff JC; Sun FF; Lee WH
Eur J Pharmacol; 1979 Dec; 60(2-3):245-8. PubMed ID: 393526
[TBL] [Abstract][Full Text] [Related]
18. Platelet prostaglandin E1 hyposensitivity in schizophrenia: decrease in cyclic AMP formation and in inhibitory effects on aggregation.
Kaiya H; Ofuji M; Nozaki M; Tsurumi K
Psychopharmacol Bull; 1990; 26(3):381-4. PubMed ID: 2177206
[TBL] [Abstract][Full Text] [Related]
19. Modulation of platelet responsiveness through selective phosphorylation of plasma membrane proteins.
Apitz-Castro R; De Murciano A
Biochim Biophys Acta; 1978 Dec; 544(3):529-39. PubMed ID: 215226
[TBL] [Abstract][Full Text] [Related]
20. Effet of prostaglandin E1 alone and in combination with theophylline or aspirin on collagen-induced platelet aggregation and on platelet nucleotides including adenosine 3':5'-cyclic monophosphate.
Ball G; Brereton GG; Fulwood M; Ireland DM; Yates P
Biochem J; 1970 Dec; 120(4):709-18. PubMed ID: 4322038
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]